Motley Fool
What One Fund's Sale of Centessa Stock Signals About the Fast-Rising Biotech Company
📊
AI Sentiment
Positive
7/10
- Home
- CNTA
as of 12-05-2025 3:45pm EST
$29.84
+$0.28
+0.93%
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
Chart Type:
Time Range:
| Founded: | 2020 | Country: | United Kingdom |
| Employees: | N/A | City: | ALTRINCHAM, CHESHIRE |
| Market Cap: | 2.3B | IPO Year: | 2021 |
| Target Price: | $35.00 | AVG Volume (30 days): | 2.1M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.82 | EPS Growth: | N/A |
| 52 Week Low/High: | $9.60 - $30.00 | Next Earning Date: | 11-05-2025 |
| Revenue: | $15,000,000 | Revenue Growth: | 118.88% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
AI-Powered CNTA Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 2 days ago
AI Recommendation
hold
Model Accuracy: 68.49%
68.49%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Centessa Pharmaceuticals plc (CNTA)
HUSSAIN IQBAL J
Sell
General Counsel
CNTA Nov 17, 2025
Avg Cost/Share
$27.64
Shares
6,000
Total Value
$165,835.20
Owned After
105,386
SEC Form 4
Bush Tia L
Sell
Chief Technology & Quality Ofc
CNTA Nov 17, 2025
Avg Cost/Share
$28.00
Shares
40,000
Total Value
$1,120,000.00
Owned After
121,503
SEC Form 4
Bush Tia L
Sell
Chief Technology & Quality Ofc
CNTA Nov 12, 2025
Avg Cost/Share
$26.00
Shares
40,000
Total Value
$1,040,000.00
Owned After
121,503
SEC Form 4
Accardi Mario Alberto
Sell
President, Orexin Program
CNTA Oct 27, 2025
Avg Cost/Share
$25.00
Shares
8,000
Total Value
$200,000.00
Owned After
194,394
SEC Form 4
HUSSAIN IQBAL J
Sell
General Counsel
CNTA Oct 15, 2025
Avg Cost/Share
$22.41
Shares
6,000
Total Value
$134,439.00
Owned After
105,386
SEC Form 4
Bush Tia L
Sell
Chief Technology & Quality Ofc
CNTA Sep 24, 2025
Avg Cost/Share
$24.00
Shares
35,000
Total Value
$840,000.00
Owned After
121,503
SEC Form 4
Accardi Mario Alberto
Sell
President, Orexin Program
CNTA Sep 16, 2025
Avg Cost/Share
$21.68
Shares
8,172
Total Value
$174,846.22
Owned After
194,394
HUSSAIN IQBAL J
Sell
General Counsel
CNTA Sep 15, 2025
Avg Cost/Share
$21.85
Shares
6,000
Total Value
$131,100.60
Owned After
105,386
SEC Form 4
HUSSAIN IQBAL J
Sell
General Counsel
CNTA Sep 10, 2025
Avg Cost/Share
$22.00
Shares
20,000
Total Value
$440,000.00
Owned After
105,386
SEC Form 4
Bush Tia L
Sell
Chief Technology & Quality Ofc
CNTA Sep 10, 2025
Avg Cost/Share
$22.00
Shares
25,000
Total Value
$550,000.00
Owned After
121,503
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| HUSSAIN IQBAL J | CNTA | General Counsel | Nov 17, 2025 | Sell | $27.64 | 6,000 | $165,835.20 | 105,386 | |
| Bush Tia L | CNTA | Chief Technology & Quality Ofc | Nov 17, 2025 | Sell | $28.00 | 40,000 | $1,120,000.00 | 121,503 | |
| Bush Tia L | CNTA | Chief Technology & Quality Ofc | Nov 12, 2025 | Sell | $26.00 | 40,000 | $1,040,000.00 | 121,503 | |
| Accardi Mario Alberto | CNTA | President, Orexin Program | Oct 27, 2025 | Sell | $25.00 | 8,000 | $200,000.00 | 194,394 | |
| HUSSAIN IQBAL J | CNTA | General Counsel | Oct 15, 2025 | Sell | $22.41 | 6,000 | $134,439.00 | 105,386 | |
| Bush Tia L | CNTA | Chief Technology & Quality Ofc | Sep 24, 2025 | Sell | $24.00 | 35,000 | $840,000.00 | 121,503 | |
| Accardi Mario Alberto | CNTA | President, Orexin Program | Sep 16, 2025 | Sell | $21.68 | 8,172 | $174,846.22 | 194,394 | |
| HUSSAIN IQBAL J | CNTA | General Counsel | Sep 15, 2025 | Sell | $21.85 | 6,000 | $131,100.60 | 105,386 | |
| HUSSAIN IQBAL J | CNTA | General Counsel | Sep 10, 2025 | Sell | $22.00 | 20,000 | $440,000.00 | 105,386 | |
| Bush Tia L | CNTA | Chief Technology & Quality Ofc | Sep 10, 2025 | Sell | $22.00 | 25,000 | $550,000.00 | 121,503 |
Latest Centessa Pharmaceuticals plc News
CNTA Breaking Stock News: Dive into CNTA Ticker-Specific Updates for Smart Investing
Compare CNTA vs Leading Stocks
See how CNTA stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "CNTA Centessa Pharmaceuticals plc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.